Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 328.31 Million CNY | 105.79% |
| 2022 | 159.54 Million CNY | 53.98% |
| 2021 | 103.61 Million CNY | 30.7% |
| 2020 | 79.27 Million CNY | 91.56% |
| 2019 | 41.38 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 376.85 Million CNY | 14.78% |
| 2024 Q2 | 376.85 Million CNY | 0.0% |
| 2023 Q2 | 208.59 Million CNY | 0.0% |
| 2023 FY | 328.31 Million CNY | 105.79% |
| 2023 Q4 | 328.31 Million CNY | 0.0% |
| 2023 Q3 | 328.31 Million CNY | 57.4% |
| 2023 Q1 | 208.59 Million CNY | 30.74% |
| 2022 Q2 | 104.58 Million CNY | 0.0% |
| 2022 Q1 | 104.58 Million CNY | 0.94% |
| 2022 FY | 159.54 Million CNY | 53.98% |
| 2022 Q4 | 159.54 Million CNY | 0.0% |
| 2022 Q3 | 159.54 Million CNY | 52.55% |
| 2021 Q2 | 84.37 Million CNY | 0.0% |
| 2021 Q4 | 103.61 Million CNY | 0.0% |
| 2021 Q3 | 103.61 Million CNY | 22.81% |
| 2021 Q1 | 84.37 Million CNY | 6.43% |
| 2021 FY | 103.61 Million CNY | 30.7% |
| 2020 FY | 79.27 Million CNY | 91.56% |
| 2020 Q4 | 79.27 Million CNY | 0.0% |
| 2020 Q3 | 79.27 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 41.38 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 243.51 Million HKD | -34.822% |